```html

Quaker’s Disease Skin Lesions

What is Quaker's disease skin lesions?

Quaker’s disease, also known as bacillary angiomatosis or peliosis hepatis when internal organs are involved, is a rare vascular proliferative disorder caused primarily by infection with Rickettsia species (most often Rickettsia australis) or Bartonella henselae. The skin manifestation—often referred to as “Quaker’s disease skin lesions”—appears as red‑purple, raised nodules or papules that can bleed easily. The nickname originated in the early 20th century when a cluster of cases was identified among members of the Quaker community in Australia, where the disease was first described.

These lesions are not just cosmetic; they reflect an underlying angiogenic (blood‑vessel‑forming) response to bacterial infection. While the disease is most commonly reported in immunocompromised individuals (e.g., HIV/AIDS patients, transplant recipients, or those on long‑term steroids), it can also affect otherwise healthy people, especially after a tick bite or cat‑scratch exposure.

Common Causes

The lesions themselves are a manifestation, not a disease. The following conditions are most frequently linked to Quaker’s disease–type skin lesions:

• Rickettsial infection (Rickettsia australis) – classic cause of Queensland tick‑typhus.
• Bartonella henselae infection – cat‑scratch disease, especially in immunocompromised hosts.
• Human immunodeficiency virus (HIV) infection – reduced immunity allows bacterial proliferation.
• Organ transplantation – immunosuppressive therapy predisposes to opportunistic infections.
• Chronic corticosteroid therapy – blunts immune response.
• Immune‑modulating biologic agents (e.g., TNF‑α inhibitors).
• Other rickettsial diseases – such as Mediterranean spotted fever (R. conorii) and Japanese spotted fever.
• Secondary bacterial infection – lesions can become colonized with Staphylococcus or Streptococcus species.
• Vasoproliferative disorders – rare overlap with Kaposi sarcoma in HIV patients.
• Rare genetic predisposition – families with inherited angiogenic pathway abnormalities may present similarly.

Associated Symptoms

When skin lesions are part of Quaker’s disease, they often occur alongside systemic or localized signs:

• Fever or chills (often low‑grade)
• Night sweats
• Fatigue or unexplained weight loss
• Regional lymphadenopathy (enlarged lymph nodes)
• Joint or muscle aches (myalgias)
• Headache or mild confusion when CNS involvement occurs
• Gastrointestinal symptoms—nausea, vomiting, or abdominal pain—if internal organs are affected
• Bleeding or rapid bruise formation from the lesions
• Underlying tick bite scar, cat‑scratch scar, or portal of entry

When to See a Doctor

Because the lesions can mimic harmless skin conditions (e.g., spider bites, insect bites, or simple bruises), it is important to seek professional evaluation when any of the following are present:

• Lesion that continues to grow or change color over a few days
• Bleeding, ulceration, or pus discharge from a lesion
• Accompanying fever > 38 °C (100.4 °F) or persistent chills
• New, unexplained lymph node enlargement
• Recent tick bite, cat scratch, or contact with animals plus skin changes
• Known immunosuppression (HIV, transplant, steroids, biologics)
• Sudden onset of multiple lesions, especially if they appear on the face, trunk, or mucous membranes

Early medical attention reduces the risk of systemic spread and complications.

Diagnosis

Diagnosing Quaker’s disease skin lesions combines a thorough history, physical examination, and targeted laboratory testing.

1. Clinical Assessment

• Detailed exposure history (ticks, cats, travel to endemic regions).
• Evaluation of lesion morphology – bright red to purple papules, often smooth, sometimes ulcerated.
• Assessment of immune status (HIV test, medication review).

2. Laboratory Studies

• Serology for Rickettsia and Bartonella – IgM/IgG titers; rising titers on convalescent sera support recent infection.
• Polymerase chain reaction (PCR) from lesion biopsy or blood to detect bacterial DNA.
• Complete blood count (CBC) – may show mild leukocytosis or anemia.
• Liver function tests – elevated transaminases if hepatic involvement.
• HIV viral load and CD4 count when indicated.

3. Skin Biopsy

A 3‑mm punch biopsy is the gold standard. Histopathology typically reveals:

• Proliferation of small vessels lined by endothelial cells.
• Prominent neutrophilic infiltrate.
• Staining for Rickettsia or Bartonella (Warthin‑Starry silver stain or immunohistochemistry).

4. Imaging (if systemic disease suspected)

• Chest X‑ray or CT to evaluate pulmonary nodules.
• Abdominal ultrasound or MRI for hepatic/splenic lesions.

Treatment Options

Effective therapy targets the underlying bacterial organism and manages the inflammatory response.

1. Antibiotic Therapy

• Doxycycline – 100 mg orally twice daily for 2–4 weeks is first‑line for both Rickettsia and Bartonella infections (CDC, 2023).
• Erythromycin or azithromycin – alternatives for patients who cannot tolerate doxycycline (e.g., pregnant women, children < 8 years).
• In severe or refractory cases, a combination of doxycycline plus a macrolide may be considered.

2. Management of Immunosuppression

• Review and possibly taper corticosteroids or biologics under specialist guidance.
• In HIV patients, optimize antiretroviral therapy to raise CD4 counts above 200 cells/µL.

3. Symptomatic care

• Topical antiseptics (e.g., chlorhexidine) for lesions that ulcerate.
• Gentle wound care – sterile gauze, non‑adhesive dressings.
• Analgesics such as acetaminophen or ibuprofen for pain/fever.

4. Surgical Intervention

Rarely required, but excision may be performed for:

• Lesions that bleed heavily despite medical therapy.
• Diagnostic uncertainty after inconclusive biopsy.

5. Follow‑up

Patients should be re‑evaluated after 2 weeks of antibiotics and then monthly until lesions have completely resolved. Persistent lesions may need repeat biopsy to exclude Kaposi sarcoma or malignancy.

Prevention Tips

Because the disease hinges on bacterial exposure and immune status, these measures can lower risk:

• Tick avoidance – wear long sleeves/pants, use EPA‑registered repellents (e.g., DEET 30 % or picaridin), and perform daily tick checks after outdoor activities.
• Cat‑scratch precautions – wash hands after handling cats, avoid rough play that could cause scratches, and keep pets’ claws trimmed.
• Vaccination & prophylaxis for at‑risk travelers – consult a travel clinic for doxycycline prophylaxis when visiting endemic regions.
• Maintain immune health – adhere to HIV medication, limit unnecessary steroid use, and follow vaccination schedules (influenza, pneumococcal, etc.).
• Prompt wound care – clean any bites, scratches, or skin breaks with soap and water; apply antiseptic.
• Regular medical reviews for people on immunosuppressive therapy to catch early infections.

Emergency Warning Signs

---

References:

1. Mayo Clinic. “Bacillary angiomatosis.” Updated 2024. https://www.mayoclinic.org
2. CDC. “Rickettsial Diseases.” 2023. https://www.cdc.gov
3. NIH National Library of Medicine. “Bartonella infections.” 2022. PubMed
4. Cleveland Clinic. “Management of Skin Lesions in Immunocompromised Patients.” 2023.
5. World Health Organization. “Guidelines for the prevention and treatment of rickettsial diseases.” 2022.

```